Mainstream

Surgery Partners reiterates 2025 guidance, targets $3.3B–$3.45B revenue while expanding high acuity and de novo growth

Surgery Partners reiterates 2025 guidance, targets $3.3B–$3.45B revenue while expanding high acuity and de novo growth

Post ContentsgryRead More

You might also be interested in reading NEO Battery enters into LOI for manufacturing facility lease and announces $4M private placement.

May 12, 2025
In Mainstream